Reserve your spot today for this Virtual Satellite Symposium!

Jointly provided by     This activity is supported by an independent educational grant from Dexcom, Inc. Monday, October 19, 2020 7:00 PM - 8:30 PM ET Click here to register!   Learn About How rtCGM and remote monitoring improves outcomes and reduces costs The latest benefits of using rtCGM over SMBG in Medicaid and Medicare plan beneficiaries The role of rtCGM as part of an employer-driven, population health management strategy The benefit design strategies used to reduce health care system burden   Expert Faculty Presenters Joseph Albright, PharmD Manager, Clinical Pharmacy Services BlueCross BlueShield North Carolina Daniel DeSalvo, MD Assistant Professor Pediatric Endocrinologist Baylor College of Medicine Texas Children's Hospital Troy Ross, MSM President & CEO Mid-America Coalition on Health Care   Who Should Attend? This activity is designed to meet the educational needs of managed care pharmacy directors, clinical pharmacists, quality directors, medical directors, members of the AMCP, and other managed health care professionals attending AMCP Nexus 2020 virtually.   Statement of Need/Program Overview Payers and employers alike place precedence on the clinical and economic burden of diabetes but are often unaware of the potential cost offsets garnered through effective, evidence-based therapy and emerging health technology interventions. In addition, the vast majority of plan members with diabetes have an A1C above ADA targets, putting them at risk for other costly comorbidities. Imprecise diabetes management culminating in hypoglycemic events can further result in excess health care resource utilization and reduced quality of life among members. To effectively address these clinical challenges and elicit improvements across 29 indices of glycemic variability and control, continuous glucose monitoring (CGM) has been endorsed by various professional endocrinology-centered organizations. This program will elucidate the clinical and economic burden of diabetes and describe multifaceted clinical and administrative strategies across the medical and pharmacy benefits to promote quality care and mitigate costs while improving outcomes for affected plan members.   Educational Objectives At the conclusion of this activity, participants should be able to demonstrate improved ability to: Describe the impact of rtCGM and remote monitoring on improving outcomes and reducing costs in high-risk, high-utilizing patient populations Assess the clinical and economic benefits of using rtCGM over SMBG in Medicaid and Medicare plan beneficiaries Review the status of ongoing plan initiatives measuring the impact of rtCGM on health status and utilization outcomes Characterize the role of rtCGM as part of an employer-driven, population health management strategy Identify appropriate benefit design strategies to reduce health care system burden and improve quality, clinical, and economic outcomes   Agenda Date and Time Monday, October 19, 2020 7:00 PM - 8:30 PM ET 7:00 PM Pre-Activity Learning Assessment and Opening Comments/Overview Joseph Albright, PharmD 7:05 PM Clinical and Economic Consequences of Imprecise Glycemic Management Daniel DeSalvo, MD 7:35 PM Implementing CGM: Real World Insights Joseph Albright, PharmD 7:55 PM Optimal Clinical and Economic Outcomes in Diabetes: The Employer Perspective Troy Ross, MSM 8:15 PM Audience Q&A Session 8:25 PM Key Takeaways and Closing Comments; Post-Activity Assessment and Evaluation 8:30 PM Adjournment

Accreditation Statements

Physician Credit This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of Medical Education Resources, Inc. (MER) and Impact Education, LLC. MER is accredited by the ACCME to provide continuing medical education for physicians. Credit Designation Medical Education Resources, Inc. designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Pharmacy Credit Medical Education Resources, Inc. (MER) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. MER designates this continuing education activity for 1.5 contact hours (0.15 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number: 0816-9999-20-162-L01-P This activity is certified as Knowledge-based CPE. Continuing Nursing Education Medical Education Resources is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. This CE activity provides 1.5 contact hours of continuing nursing education. Provider approved by the California Board of Registered Nursing, Provider Number 12299, for 1.5 contact hours.

Disclosure of Conflicts of Interest It is the policy of Medical Education Resources, Inc. to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, MER identifies conflicts of interest with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Conflicts are resolved by MER to ensure that all scientific research referred to, reported, or used in a continuing education activity conforms to the generally accepted standards of experimental design, data collection, and analysis. Hardware/Software Requirements Compatible with Internet Explorer 6 and up, Mozilla Firefox 3 and up, Safari 4.0, and Google Chrome 10 and up. Fee Information No additional fee is required to attend this CME/CPE activity. If you have any questions, please call (215) 619-8812 or email info@impactedu.net.